Datasets:
SKT27182
/
NER_processed_data

Dataset card Data Studio Files
xet
Community
1
id
stringlengths
11
11
tags
stringlengths
10
777
text
stringlengths
2
1.5k
dataset_num
int64
1
3
tokens
list
ner_tags
list
NCT03042897
16:31:chronic_disease,33:50:chronic_disease,54:75:chronic_disease
History of any musculoskeletal, cardiorespiratory or neurological diseases that preclude the participation in exercise
3
[ "History", "of", "any", "musculoskeletal", ",", "cardiorespiratory", "or", "neurological", "diseases", "that", "preclude", "the", "participation", "in", "exercise" ]
[ 0, 0, 0, 2, 0, 2, 0, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT02824276
24:52:chronic_disease
current (i.e., active) substance use disorder (SUD)
3
[ "current", "(", "i.e.", ",", "active", ")", "substance", "use", "disorder", "(", "SUD", ")" ]
[ 0, 0, 0, 0, 0, 0, 2, 2, 2, 2, 0, 0 ]
NCT02474667
34:55:treatment
Patients cannot be given another investigational agent during the course of this study (through Day 360)
3
[ "Patients", "can", "not", "be", "given", "another", "investigational", "agent", "during", "the", "course", "of", "this", "study", "(", "through", "Day", "360", ")" ]
[ 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02333162
1:35:chronic_disease
Human immunodeficiency virus (HIV)-negative
3
[ "Human", "immunodeficiency", "virus", "(", "HIV", ")", "-negative" ]
[ 2, 2, 2, 2, 0, 0, 0 ]
NCT00338377
,,62:103:treatment
Absolute neutrophil count greater than or equal to 750/mm3. (Turnstile II - Chemotherapy/Cell Infusion- Inclusion Criteria)
3
[ "Absolute", "neutrophil", "count", "greater", "than", "or", "equal", "to", "750/mm3", ".", "(", "Turnstile", "II", "-", "Chemotherapy/Cell", "Infusion-", "Inclusion", "Criteria", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 0, 0, 0 ]
NCT02143726
1:18:treatment,7:18:treatment,7:10:treatment,,
Prior RAI therapy is allowed if ≥ 90 days prior to registration on this protocol and evidence of progression (as defined above) has been documented in the interim (a diagnostic study using < 10 mCi of RAI is not considered RAI therapy)
3
[ "Prior", "RAI", "therapy", "is", "allowed", "if", "≥", "90", "days", "prior", "to", "registration", "on", "this", "protocol", "and", "evidence", "of", "progression", "(", "as", "defined", "above", ")", "has", "been", "documented", "in", "the", "interim", "(", "a", "diagnostic", "study", "using", "<", "10", "mCi", "of", "RAI", "is", "not", "considered", "RAI", "therapy", ")" ]
[ 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03065465
21:53:treatment
requires continuous intravenous vasopressor infusion for blood pressure support
3
[ "requires", "continuous", "intravenous", "vasopressor", "infusion", "for", "blood", "pressure", "support" ]
[ 0, 0, 1, 1, 1, 0, 0, 0, 0 ]
NCT02278250
23:30:treatment,85:96:treatment,100:109:treatment
During prior platinum therapy, requirement for dose reduction or discontinuation of carboplatin or cisplatin for toxicity or lack of tolerability
3
[ "During", "prior", "platinum", "therapy", ",", "requirement", "for", "dose", "reduction", "or", "discontinuation", "of", "carboplatin", "or", "cisplatin", "for", "toxicity", "or", "lack", "of", "tolerability" ]
[ 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0 ]
NCT01239095
21:33:cancer
Patients with other malignancies are not eligible
3
[ "Patients", "with", "other", "malignancies", "are", "not", "eligible" ]
[ 0, 0, 0, 3, 0, 0, 0 ]
NCT02203513
1:22:chronic_disease,
myocardial infarction within the last 3 months
3
[ "myocardial", "infarction", "within", "the", "last", "3", "months" ]
[ 2, 2, 0, 0, 0, 0, 0 ]
NCT02561988
1:24:cancer
metastases to the brain
3
[ "metastases", "to", "the", "brain" ]
[ 3, 3, 3, 3 ]
NCT01766297
1:32:cancer
ductal carcinoma in situ (DCIS)
3
[ "ductal", "carcinoma", "in", "situ", "(", "DCIS", ")" ]
[ 3, 3, 3, 3, 3, 0, 0 ]
NCT01618357
1:17:treatment
Hepatic Function
3
[ "Hepatic", "Function" ]
[ 1, 1 ]
NCT03037879
22:30:treatment,32:47:treatment,52:64:treatment
Currently prescribed steroids, benzodiazepines, or neuroleptics
3
[ "Currently", "prescribed", "steroids", ",", "benzodiazepines", ",", "or", "neuroleptics" ]
[ 0, 0, 1, 0, 1, 0, 0, 1 ]
NCT01459107
1:17:chronic_disease
Hepatitis B or C
3
[ "Hepatitis", "B", "or", "C" ]
[ 2, 2, 2, 2 ]
NCT02143726
1:14:chronic_disease
Liver disease
3
[ "Liver", "disease" ]
[ 2, 2 ]
NCT03032432
12:32:chronic_disease
History of rheumatoid arthritis
3
[ "History", "of", "rheumatoid", "arthritis" ]
[ 0, 0, 2, 2 ]
NCT01925131
56:79:treatment
Patients must be refractory or have relapsed following prior induction therapy
3
[ "Patients", "must", "be", "refractory", "or", "have", "relapsed", "following", "prior", "induction", "therapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1 ]
NCT01804465
27:48:chronic_disease,123:133:treatment,227:235:chronic_disease
Any underlying medical or psychiatric condition, which in the opinion of the investigator will make the administration of ipilimumab hazardous or obscure the interpretation of AEs, such as a condition associated with frequent diarrhea
3
[ "Any", "underlying", "medical", "or", "psychiatric", "condition", ",", "which", "in", "the", "opinion", "of", "the", "investigator", "will", "make", "the", "administration", "of", "ipilimumab", "hazardous", "or", "obscure", "the", "interpretation", "of", "AEs", ",", "such", "as", "a", "condition", "associated", "with", "frequent", "diarrhea" ]
[ 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2 ]
NCT03096886
1:18:chronic_disease
learning disorder
3
[ "learning", "disorder" ]
[ 2, 2 ]
NCT02303977
,,86:96:treatment
Patients must agree to continue contraception for 3 months from the date of the last study drug administration
3
[ "Patients", "must", "agree", "to", "continue", "contraception", "for", "3", "months", "from", "the", "date", "of", "the", "last", "study", "drug", "administration" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0 ]
NCT01766297
1:28:cancer,37:44:cancer,48:56:cancer
Non-epithelial malignancies such as sarcoma or lymphoma
3
[ "Non-epithelial", "malignancies", "such", "as", "sarcoma", "or", "lymphoma" ]
[ 3, 3, 0, 0, 3, 0, 3 ]
NCT01804634
1:8:chronic_disease
Cardiac
3
[ "Cardiac" ]
[ 2 ]
NCT02003222
,243:296:treatment
Diagnostic bone marrow and peripheral blood specimens must be submitted for immunophenotyping and selected molecular testing, and the establishment of BCR/ABL status; testing will be performed by the Eastern Cooperative Oncology Group (ECOG)-American College of Radiation Imaging Network (ACRIN) Leukemia Translational Research Laboratory (LTRL) and reported to the institution
3
[ "Diagnostic", "bone", "marrow", "and", "peripheral", "blood", "specimens", "must", "be", "submitted", "for", "immunophenotyping", "and", "selected", "molecular", "testing", ",", "and", "the", "establishment", "of", "BCR/ABL", "status", ";", "testing", "will", "be", "performed", "by", "the", "Eastern", "Cooperative", "Oncology", "Group", "(", "ECOG", ")", "-American", "College", "of", "Radiation", "Imaging", "Network", "(", "ACRIN", ")", "Leukemia", "Translational", "Research", "Laboratory", "(", "LTRL", ")", "and", "reported", "to", "the", "institution" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02758847
118:161:treatment
Iliac inflow or Tibial outflow interventions can be done at the discretion of the investigator with standard balloon Percutaneous Transluminal Angioplasty (PTA)
3
[ "Iliac", "inflow", "or", "Tibial", "outflow", "interventions", "can", "be", "done", "at", "the", "discretion", "of", "the", "investigator", "with", "standard", "balloon", "Percutaneous", "Transluminal", "Angioplasty", "(", "PTA", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0 ]
NCT02148003
58:82:chronic_disease
Subjects who have chronic back pain attributed to lumbar facet joints arthropathy based on clinical evaluation (paraspinal tenderness and/or facet loading test in the absence of signs and symptoms suggestive of focal neurological deficits)
3
[ "Subjects", "who", "have", "chronic", "back", "pain", "attributed", "to", "lumbar", "facet", "joints", "arthropathy", "based", "on", "clinical", "evaluation", "(", "paraspinal", "tenderness", "and/or", "facet", "loading", "test", "in", "the", "absence", "of", "signs", "and", "symptoms", "suggestive", "of", "focal", "neurological", "deficits", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02068092
18:31:cancer,,105:114:chronic_disease,122:140:treatment
Elevated risk of breast cancer as defined by at least one of the following categories and have declined tamoxifen and/or raloxifene therapy
3
[ "Elevated", "risk", "of", "breast", "cancer", "as", "defined", "by", "at", "least", "one", "of", "the", "following", "categories", "and", "have", "declined", "tamoxifen", "and/or", "raloxifene", "therapy" ]
[ 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 1, 1 ]
NCT02674529
7:33:chronic_disease
other Axis I psychotic disorders
3
[ "other", "Axis", "I", "psychotic", "disorders" ]
[ 0, 2, 2, 2, 2 ]
NCT02762825
1:56:chronic_disease
moderate to severe (grade II-III) diastolic dysfunction
3
[ "moderate", "to", "severe", "(", "grade", "II-III", ")", "diastolic", "dysfunction" ]
[ 2, 2, 2, 2, 2, 2, 2, 0, 0 ]
NCT01459107
1:19:chronic_disease
Viral encephalitis
3
[ "Viral", "encephalitis" ]
[ 2, 2 ]
NCT02048722
23:30:treatment
Prophylactic doses of heparin
3
[ "Prophylactic", "doses", "of", "heparin" ]
[ 0, 0, 0, 1 ]
NCT02109627
1:13:treatment,15:24:treatment,29:42:treatment,,135:146:treatment,151:173:treatment
Chemotherapy, radiation, or immunotherapy, within 2 weeks prior to study entry, other than those specified in the inclusion criteria (hydroxyurea and hypomethylating agents)
3
[ "Chemotherapy", ",", "radiation", ",", "or", "immunotherapy", ",", "within", "2", "weeks", "prior", "to", "study", "entry", ",", "other", "than", "those", "specified", "in", "the", "inclusion", "criteria", "(", "hydroxyurea", "and", "hypomethylating", "agents", ")" ]
[ 1, 0, 1, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 1, 0 ]
NCT02791646
15:43:chronic_disease,22:43:chronic_disease,51:69:chronic_disease,116:131:chronic_disease
presence of a severe psychiatric condition (i.e., psychotic disorder or episode) or a psychiatric condition (e.g., suicidal intent) that would contraindicate safe participation in the study as indicated by the medical chart, treating oncologist, or interactions with the medical/study staff
3
[ "presence", "of", "a", "severe", "psychiatric", "condition", "(", "i.e.", ",", "psychotic", "disorder", "or", "episode", ")", "or", "a", "psychiatric", "condition", "(", "e.g.", ",", "suicidal", "intent", ")", "that", "would", "contraindicate", "safe", "participation", "in", "the", "study", "as", "indicated", "by", "the", "medical", "chart", ",", "treating", "oncologist", ",", "or", "interactions", "with", "the", "medical/study", "staff" ]
[ 0, 0, 0, 2, 2, 2, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02252081
12:35:treatment,39:45:treatment,,104:125:treatment
Use of any investigational product or device within 30 days prior to screening, or requirement for any investigational agent prior to completion of all scheduled study assessments
3
[ "Use", "of", "any", "investigational", "product", "or", "device", "within", "30", "days", "prior", "to", "screening", ",", "or", "requirement", "for", "any", "investigational", "agent", "prior", "to", "completion", "of", "all", "scheduled", "study", "assessments" ]
[ 0, 0, 0, 1, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02498301
22:61:treatment,
Subject received any systemic or gastrointestinal antibiotic in the 7 days prior to enrollment
3
[ "Subject", "received", "any", "systemic", "or", "gastrointestinal", "antibiotic", "in", "the", "7", "days", "prior", "to", "enrollment" ]
[ 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT02856412
27:50:allergy_name
Contraindications for the exercise treadmill test
3
[ "Contraindications", "for", "the", "exercise", "treadmill", "test" ]
[ 0, 0, 0, 4, 4, 4 ]
NCT02488967
8:17:chronic_disease,21:38:chronic_disease,69:80:treatment
Active infection or chronic infection requiring chronic suppressive antibiotics
3
[ "Active", "infection", "or", "chronic", "infection", "requiring", "chronic", "suppressive", "antibiotics" ]
[ 0, 2, 0, 2, 2, 0, 0, 0, 1 ]
NCT01928576
42:52:cancer,54:56:cancer,70:96:cancer
Patients must have histologically proven stage IIIB, IV or recurrent non-small cell lung cancer
3
[ "Patients", "must", "have", "histologically", "proven", "stage", "IIIB", ",", "IV", "or", "recurrent", "non-small", "cell", "lung", "cancer" ]
[ 0, 0, 0, 0, 0, 3, 3, 0, 3, 0, 0, 3, 3, 3, 3 ]
NCT02383927
7:16:chronic_disease,22:25:chronic_disease,33:49:chronic_disease,55:66:chronic_disease,70:81:chronic_disease
Known infection with HIV, or an active infection with hepatitis B or hepatitis C
3
[ "Known", "infection", "with", "HIV", ",", "or", "an", "active", "infection", "with", "hepatitis", "B", "or", "hepatitis", "C" ]
[ 0, 2, 0, 2, 0, 0, 0, 2, 2, 0, 2, 2, 0, 0, 0 ]
NCT02544373
22:24:chronic_disease,
Evidence of clinical MS relapse within the last 30 days prior to enrollment
3
[ "Evidence", "of", "clinical", "MS", "relapse", "within", "the", "last", "30", "days", "prior", "to", "enrollment" ]
[ 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00930228
1:13:chronic_disease
Virilization
3
[ "Virilization" ]
[ 2 ]
NCT01908777
1:46:cancer
Primary cutaneous gamma/delta T-cell lymphoma
3
[ "Primary", "cutaneous", "gamma/delta", "T-cell", "lymphoma" ]
[ 3, 3, 3, 3, 3 ]
NCT01962415
17:26:chronic_disease
Other inherited metabolic disorders
3
[ "Other", "inherited", "metabolic", "disorders" ]
[ 0, 0, 2, 0 ]
NCT02053246
7:16:chronic_disease
Liver cirrhosis
3
[ "Liver", "cirrhosis" ]
[ 0, 2 ]
NCT01653080
1:44:chronic_disease
Acute or chronic severe renal insufficiency
3
[ "Acute", "or", "chronic", "severe", "renal", "insufficiency" ]
[ 2, 2, 2, 2, 2, 2 ]
NCT02665962
26:47:treatment,49:61:treatment,63:124:treatment,,
Scheduled for definitive surgical intervention (hysterectomy, bilateral salpingoopherectomy with or without lymphadenectomy) in the following 2-3 weeks as part of the standard of care
3
[ "Scheduled", "for", "definitive", "surgical", "intervention", "(", "hysterectomy", ",", "bilateral", "salpingoopherectomy", "with", "or", "without", "lymphadenectomy", ")", "in", "the", "following", "2-3", "weeks", "as", "part", "of", "the", "standard", "of", "care" ]
[ 0, 0, 0, 1, 1, 0, 1, 0, 1, 1, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01508390
10:22:treatment
No prior radiotherapy to the pelvis
3
[ "No", "prior", "radiotherapy", "to", "the", "pelvis" ]
[ 0, 0, 1, 0, 0, 0 ]
NCT02685358
26:33:chronic_disease
current intent to commit suicide
3
[ "current", "intent", "to", "commit", "suicide" ]
[ 0, 0, 0, 0, 2 ]
NCT02553642
98:117:allergy_name
History of allergy to study drug component or history of severe hypersensitivity reaction to any monoclonal antibody
3
[ "History", "of", "allergy", "to", "study", "drug", "component", "or", "history", "of", "severe", "hypersensitivity", "reaction", "to", "any", "monoclonal", "antibody" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 4 ]
NCT03032432
1:14:chronic_disease
infraspinatus
3
[ "infraspinatus" ]
[ 2 ]
NCT02323698
1:9:chronic_disease
Diabetes
3
[ "Diabetes" ]
[ 2 ]
NCT02621944
33:42:treatment,,,
a cord blood/first hour of life blood gas with pH > 7.0 and < 7.15
3
[ "a", "cord", "blood/first", "hour", "of", "life", "blood", "gas", "with", "pH", ">", "7.0", "and", "<", "7.15" ]
[ 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01988246
23:29:treatment,34:42:treatment,,85:92:treatment
Use of topical ocular NSAIDS and steroids, in the study eye, within 7 days prior to surgery
3
[ "Use", "of", "topical", "ocular", "NSAIDS", "and", "steroids", ",", "in", "the", "study", "eye", ",", "within", "7", "days", "prior", "to", "surgery" ]
[ 0, 0, 0, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02177838
,53:81:treatment,83:107:treatment,161:185:chronic_disease,189:199:chronic_disease,
Patients who have had either myocardial infarction, coronary artery bypass graft, coronary artery stenting, hospital admission for heart related issues such as congestive heart failure or arrhythmia within the last 3 months, will not be allowed on protocol
3
[ "Patients", "who", "have", "had", "either", "myocardial", "infarction", ",", "coronary", "artery", "bypass", "graft", ",", "coronary", "artery", "stenting", ",", "hospital", "admission", "for", "heart", "related", "issues", "such", "as", "congestive", "heart", "failure", "or", "arrhythmia", "within", "the", "last", "3", "months", ",", "will", "not", "be", "allowed", "on", "protocol" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02922023
17:43:chronic_disease,45:79:chronic_disease,81:89:chronic_disease,91:112:chronic_disease
Conditions with visual field deterioration (Anterior Ischemic Optic Neuropathy, Glaucoma, Optic Nerve Disorders)
3
[ "Conditions", "with", "visual", "field", "deterioration", "(", "Anterior", "Ischemic", "Optic", "Neuropathy", ",", "Glaucoma", ",", "Optic", "Nerve", "Disorders", ")" ]
[ 0, 0, 2, 2, 2, 0, 2, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0 ]
NCT00358657
1:4:chronic_disease
SAA diagnostic criteria may be applied to assessment at initial diagnosis or follow-up assessments
3
[ "SAA", "diagnostic", "criteria", "may", "be", "applied", "to", "assessment", "at", "initial", "diagnosis", "or", "follow-up", "assessments" ]
[ 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02769000
18:41:treatment,55:77:treatment,95:98:treatment
Able to complete neurocognitive function assessments, psychological function assessments, and QOL assessments administered at screening visit
3
[ "Able", "to", "complete", "neurocognitive", "function", "assessments", ",", "psychological", "function", "assessments", ",", "and", "QOL", "assessments", "administered", "at", "screening", "visit" ]
[ 0, 0, 0, 1, 1, 0, 0, 1, 1, 0, 0, 0, 1, 0, 0, 0, 0, 0 ]
NCT02522715
15:35:chronic_disease,78:94:chronic_disease,96:117:chronic_disease,131:155:chronic_disease,157:181:chronic_disease,183:201:chronic_disease,206:243:chronic_disease
Uncontrolled, intercurrent illness including, but not limited to, ongoing or active infection, uncontrolled diabetes, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements
3
[ "Uncontrolled", ",", "intercurrent", "illness", "including", ",", "but", "not", "limited", "to", ",", "ongoing", "or", "active", "infection", ",", "uncontrolled", "diabetes", ",", "symptomatic", "congestive", "heart", "failure", ",", "unstable", "angina", "pectoris", ",", "cardiac", "arrhythmia", ",", "or", "psychiatric", "illness/social", "situations", "that", "would", "limit", "compliance", "with", "study", "requirements" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 2, 2, 0, 0, 2, 2, 2, 0, 2, 2, 2, 0, 2, 2, 0, 0, 2, 2, 2, 0, 0, 0, 0, 0, 0, 0 ]
NCT03171168
28:58:chronic_disease
Patients with diagnosis of avascular necrosis of the knee
3
[ "Patients", "with", "diagnosis", "of", "avascular", "necrosis", "of", "the", "knee" ]
[ 0, 0, 0, 0, 2, 2, 2, 2, 2 ]
NCT03043742
13:38:chronic_disease
Evidence of left ventricular thrombus
3
[ "Evidence", "of", "left", "ventricular", "thrombus" ]
[ 0, 0, 2, 2, 2 ]
NCT02389309
66:77:cancer,132:144:cancer,164:182:cancer,187:207:cancer
Patients must have had a previous histological verification of a solid tumor at the original diagnosis and/or recurrence including brain tumors; for patients with brain stem gliomas and optic pathway tumors, the requirement for histological evaluation may be waived
3
[ "Patients", "must", "have", "had", "a", "previous", "histological", "verification", "of", "a", "solid", "tumor", "at", "the", "original", "diagnosis", "and/or", "recurrence", "including", "brain", "tumors", ";", "for", "patients", "with", "brain", "stem", "gliomas", "and", "optic", "pathway", "tumors", ",", "the", "requirement", "for", "histological", "evaluation", "may", "be", "waived" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02379377
33:50:chronic_disease,,
Patients with poorly controlled diabetes mellitus (fasting blood glucose level > 200 mg/dL)
3
[ "Patients", "with", "poorly", "controlled", "diabetes", "mellitus", "(", "fasting", "blood", "glucose", "level", ">", "200", "mg/dL", ")" ]
[ 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT00896493
,,14:50:cancer,,79:104:treatment,131:147:treatment
Stage IIB-IV mycosis fungoides or Sezary syndrome, who have failed at least 1 standard systemic therapy or are not candidates for standard therapy
3
[ "Stage", "IIB-IV", "mycosis", "fungoides", "or", "Sezary", "syndrome", ",", "who", "have", "failed", "at", "least", "1", "standard", "systemic", "therapy", "or", "are", "not", "candidates", "for", "standard", "therapy" ]
[ 0, 0, 3, 3, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0 ]
NCT01925573
31:44:treatment,46:57:treatment,74:90:chronic_disease,138:145:treatment
9 Minimum interval since last major surgery, open biopsy, or significant traumatic injury is 4 weeks 10 Minimum interval since last drug therapy
3
[ "9", "Minimum", "interval", "since", "last", "major", "surgery", ",", "open", "biopsy", ",", "or", "significant", "traumatic", "injury", "is", "4", "weeks", "10", "Minimum", "interval", "since", "last", "drug", "therapy" ]
[ 0, 0, 0, 0, 0, 1, 1, 0, 1, 1, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1 ]
NCT02379520
8:30:chronic_disease
Severe intercurrent infection
3
[ "Severe", "intercurrent", "infection" ]
[ 0, 2, 2 ]
NCT02621944
11:38:chronic_disease,40:56:chronic_disease,62:74:chronic_disease
suspected inborn errors of metabolism (elevated ammonia) and hypoglycemia
3
[ "suspected", "inborn", "errors", "of", "metabolism", "(", "elevated", "ammonia", ")", "and", "hypoglycemia" ]
[ 0, 2, 2, 2, 2, 0, 2, 2, 0, 0, 2 ]
NCT02901314
1:9:chronic_disease,11:34:chronic_disease,38:44:cancer,48:123:chronic_disease
cachexia, end stage liver disease or cancer or non-ambulatory New York Heart Association functional class IV heart failure
3
[ "cachexia", ",", "end", "stage", "liver", "disease", "or", "cancer", "or", "non-ambulatory", "New", "York", "Heart", "Association", "functional", "class", "IV", "heart", "failure" ]
[ 2, 0, 2, 2, 2, 2, 0, 3, 0, 2, 2, 2, 2, 2, 2, 2, 2, 2, 2 ]
NCT02048371
44:56:cancer,
Concurrent, clinically significant, active malignancies within 12 months of study enrollment
3
[ "Concurrent", ",", "clinically", "significant", ",", "active", "malignancies", "within", "12", "months", "of", "study", "enrollment" ]
[ 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0 ]
NCT02845453
45:75:treatment,,,,
If subject in restricted setting/care (e.g. detox or residential treatment) for ≤ 2 weeks, then use ≥ 50% of days while outside of restricted setting (e.g. 7 days of substance use out of 14 days in unrestricted setting)
3
[ "If", "subject", "in", "restricted", "setting/care", "(", "e.g", ".", "detox", "or", "residential", "treatment", ")", "for", "≤", "2", "weeks", ",", "then", "use", "≥", "50", "%", "of", "days", "while", "outside", "of", "restricted", "setting", "(", "e.g", ".", "7", "days", "of", "substance", "use", "out", "of", "14", "days", "in", "unrestricted", "setting", ")" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02587403
1:22:chronic_disease,,,
Uncontrolled diabetes (i.e. known HbA1C value > 7% within the last 6 weeks)
3
[ "Uncontrolled", "diabetes", "(", "i.e", ".", "known", "HbA1C", "value", ">", "7", "%", "within", "the", "last", "6", "weeks", ")" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT03117556
16:46:cancer
Diagnosed with stage III/IV pancreatic cancer
3
[ "Diagnosed", "with", "stage", "III/IV", "pancreatic", "cancer" ]
[ 0, 0, 3, 3, 3, 3 ]
NCT02446457
,75:88:treatment,
agree to use two methods of contraception starting with the first dose of study therapy through 120 days after the last dose of study therapy
3
[ "agree", "to", "use", "two", "methods", "of", "contraception", "starting", "with", "the", "first", "dose", "of", "study", "therapy", "through", "120", "days", "after", "the", "last", "dose", "of", "study", "therapy" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01819480
1:37:cancer
supraglottic squamous cell carcinoma
3
[ "supraglottic", "squamous", "cell", "carcinoma" ]
[ 3, 3, 3, 3 ]
NCT00929006
1:19:chronic_disease,,62:64:chronic_disease,65:69:chronic_disease,
Hyperprolactinemia: Mild prolactin elevations may be seen in HA/PCOS, and elevations within 20% higher than the upper limit of normal will be accepted in this group
3
[ "Hyperprolactinemia", ":", "Mild", "prolactin", "elevations", "may", "be", "seen", "in", "HA/PCOS", ",", "and", "elevations", "within", "20", "%", "higher", "than", "the", "upper", "limit", "of", "normal", "will", "be", "accepted", "in", "this", "group" ]
[ 2, 0, 0, 0, 0, 0, 0, 0, 0, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02278250
33:52:treatment
Ongoing toxic manifestations of previous treatments
3
[ "Ongoing", "toxic", "manifestations", "of", "previous", "treatments" ]
[ 0, 0, 0, 0, 1, 1 ]
NCT01522768
,25:42:cancer,77:84:chronic_disease,86:103:chronic_disease,109:124:cancer,,,197:207:treatment,
At least one measurable metastatic lesion according to RECIST 1.1 criteria. Ascites, pleural effusions, and bone metastases are not considered measurable. Minimum indicator lesion size = 10 mm by helical CT or = 20 mm by conventional techniques. Pathological nodes must be = 15 mm by the short axis to be considered measurable
3
[ "At", "least", "one", "measurable", "metastatic", "lesion", "according", "to", "RECIST", "1.1", "criteria", ".", "Ascites", ",", "pleural", "effusions", ",", "and", "bone", "metastases", "are", "not", "considered", "measurable", ".", "Minimum", "indicator", "lesion", "size", "=", "10", "mm", "by", "helical", "CT", "or", "=", "20", "mm", "by", "conventional", "techniques", ".", "Pathological", "nodes", "must", "be", "=", "15", "mm", "by", "the", "short", "axis", "to", "be", "considered", "measurable" ]
[ 0, 0, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 2, 0, 2, 2, 0, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02033616
1:17:chronic_disease,111:125:chronic_disease,129:147:chronic_disease
Active infection or other active medical condition that could be eminently life-threatening, including active blood clotting or bleeding diathesis
3
[ "Active", "infection", "or", "other", "active", "medical", "condition", "that", "could", "be", "eminently", "life-threatening", ",", "including", "active", "blood", "clotting", "or", "bleeding", "diathesis" ]
[ 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 0, 2, 2 ]
NCT01591356
12:46:chronic_disease,42:45:chronic_disease,87:109:treatment
History of human immunodeficiency virus (HIV) or HIV-positive patients on combination antiretroviral therapy are ineligible
3
[ "History", "of", "human", "immunodeficiency", "virus", "(", "HIV", ")", "or", "HIV-positive", "patients", "on", "combination", "antiretroviral", "therapy", "are", "ineligible" ]
[ 0, 0, 2, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0, 1, 1, 0, 0 ]
NCT02360579
15:39:cancer
Patients with melanoma of uveal/ocular origin
3
[ "Patients", "with", "melanoma", "of", "uveal/ocular", "origin" ]
[ 0, 0, 3, 3, 3, 0 ]
NCT02397889
58:84:chronic_disease
Patients judged clinically to be at serious and imminent suicidal or homicidal risk
3
[ "Patients", "judged", "clinically", "to", "be", "at", "serious", "and", "imminent", "suicidal", "or", "homicidal", "risk" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 2, 2, 2, 2 ]
NCT02520713
24:29:cancer,71:89:treatment,232:250:treatment
Refractory, defined as tumor progression after initiation of standard first line therapy without having achieved a prior partial or complete remission OR Biopsy proven residual disease at the completion of planned standard initial front-line therapy
3
[ "Refractory", ",", "defined", "as", "tumor", "progression", "after", "initiation", "of", "standard", "first", "line", "therapy", "without", "having", "achieved", "a", "prior", "partial", "or", "complete", "remission", "OR", "Biopsy", "proven", "residual", "disease", "at", "the", "completion", "of", "planned", "standard", "initial", "front-line", "therapy" ]
[ 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02074631
11:36:treatment
Impending invasive dental procedure that would be expected to occur during study participation (through Day 360)
3
[ "Impending", "invasive", "dental", "procedure", "that", "would", "be", "expected", "to", "occur", "during", "study", "participation", "(", "through", "Day", "360", ")" ]
[ 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01903330
1:6:chronic_disease
ulcer
3
[ "ulcer" ]
[ 2 ]
NCT02555189
1:16:treatment,20:37:treatment,45:63:treatment
Planned surgery or radiation therapy during protocol treatment
3
[ "Planned", "surgery", "or", "radiation", "therapy", "during", "protocol", "treatment" ]
[ 1, 1, 0, 1, 1, 0, 1, 1 ]
NCT02723994
21:37:chronic_disease
Positive screen for hepatitis B or C
3
[ "Positive", "screen", "for", "hepatitis", "B", "or", "C" ]
[ 0, 0, 0, 2, 2, 2, 2 ]
NCT02004275
15:22:treatment,50:59:treatment,185:192:cancer,249:265:treatment,267:277:treatment,282:295:treatment
a new line of therapy also begins when a planned treatment-free interval is interrupted by the need to start treatment due to disease relapse/progression (e.g. a patient with relapsed myeloma achieves a partial response after a planned 8 cycles of cyclophosphamide, bortezomib and dexamethasone, enjoys an 8-month period off therapy but then experiences disease progression requiring re-initiation of therapy)
3
[ "a", "new", "line", "of", "therapy", "also", "begins", "when", "a", "planned", "treatment-free", "interval", "is", "interrupted", "by", "the", "need", "to", "start", "treatment", "due", "to", "disease", "relapse/progression", "(", "e.g", ".", "a", "patient", "with", "relapsed", "myeloma", "achieves", "a", "partial", "response", "after", "a", "planned", "8", "cycles", "of", "cyclophosphamide", ",", "bortezomib", "and", "dexamethasone", ",", "enjoys", "an", "8-month", "period", "off", "therapy", "but", "then", "experiences", "disease", "progression", "requiring", "re-initiation", "of", "therapy", ")" ]
[ 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 0, 1, 0, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02816736
60:76:treatment
Currently hospitalized and listed status 1A, 1B or 1-4 for heart transplant
3
[ "Currently", "hospitalized", "and", "listed", "status", "1A", ",", "1B", "or", "1-4", "for", "heart", "transplant" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT01614197
,57:73:treatment
At least 42 days must have elapsed if other substantial marrow radiation
3
[ "At", "least", "42", "days", "must", "have", "elapsed", "if", "other", "substantial", "marrow", "radiation" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT01815359
12:35:chronic_disease
History of cerebrovascular disease. that would limit study compliance or place the patient at unacceptable risk for participation in the study
3
[ "History", "of", "cerebrovascular", "disease", ".", "that", "would", "limit", "study", "compliance", "or", "place", "the", "patient", "at", "unacceptable", "risk", "for", "participation", "in", "the", "study" ]
[ 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01803451
18:35:treatment
Individuals with bariatric surgery
3
[ "Individuals", "with", "bariatric", "surgery" ]
[ 0, 0, 1, 1 ]
NCT02465541
17:33:chronic_disease,58:79:chronic_disease,89:104:chronic_disease,118:142:chronic_disease,144:169:chronic_disease
Severe heart or systemic disease: evidence of documented myocardial infarction, chronic unstable angina, symptomatic congestive heart failure, uncontrolled hypertension
3
[ "Severe", "heart", "or", "systemic", "disease", ":", "evidence", "of", "documented", "myocardial", "infarction", ",", "chronic", "unstable", "angina", ",", "symptomatic", "congestive", "heart", "failure", ",", "uncontrolled", "hypertension" ]
[ 0, 0, 0, 2, 2, 0, 0, 0, 0, 2, 2, 0, 0, 2, 2, 0, 0, 2, 2, 2, 0, 2, 2 ]
NCT02359097
47:63:chronic_disease
Subjects with clinically significant signs of uncal herniation, such as acute pupillary enlargement, rapidly developing motor changes (over hours), or rapidly decreasing level of consciousness
3
[ "Subjects", "with", "clinically", "significant", "signs", "of", "uncal", "herniation", ",", "such", "as", "acute", "pupillary", "enlargement", ",", "rapidly", "developing", "motor", "changes", "(", "over", "hours", ")", ",", "or", "rapidly", "decreasing", "level", "of", "consciousness" ]
[ 0, 0, 0, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT01959204
27:31:allergy_name,43:47:allergy_name,85:94:allergy_name,115:120:allergy_name
Has a history of relevant drug allergies, food allergies, or both (i.e., allergy to oxycodone, allergy to related drugs, or any significant food allergy that could interfere with the study)
3
[ "Has", "a", "history", "of", "relevant", "drug", "allergies", ",", "food", "allergies", ",", "or", "both", "(", "i.e.", ",", "allergy", "to", "oxycodone", ",", "allergy", "to", "related", "drugs", ",", "or", "any", "significant", "food", "allergy", "that", "could", "interfere", "with", "the", "study", ")" ]
[ 0, 0, 0, 0, 0, 4, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 4, 0, 0, 0, 0, 4, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02589938
15:42:treatment
have received bilateral radiation therapy, and subsequently developed grade 2 or 3 xerostomia, according to modified RTOG scale
3
[ "have", "received", "bilateral", "radiation", "therapy", ",", "and", "subsequently", "developed", "grade", "2", "or", "3", "xerostomia", ",", "according", "to", "modified", "RTOG", "scale" ]
[ 0, 0, 1, 1, 1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02414269
21:55:chronic_disease,57:68:chronic_disease,94:105:chronic_disease
Negative screen for human immunodeficiency virus (HIV), hepatitis B virus (HBV) antigen, and hepatitis C virus (HCV)
3
[ "Negative", "screen", "for", "human", "immunodeficiency", "virus", "(", "HIV", ")", ",", "hepatitis", "B", "virus", "(", "HBV", ")", "antigen", ",", "and", "hepatitis", "C", "virus", "(", "HCV", ")" ]
[ 0, 0, 0, 2, 2, 2, 2, 0, 0, 0, 2, 2, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0 ]
NCT02346526
,,134:144:treatment
Subjects must agree to use adequate contraception beginning at the signing of the ICF until at least 6 months after the last dose of study drug
3
[ "Subjects", "must", "agree", "to", "use", "adequate", "contraception", "beginning", "at", "the", "signing", "of", "the", "ICF", "until", "at", "least", "6", "months", "after", "the", "last", "dose", "of", "study", "drug" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02354547
,64:83:treatment
At least 3 half-lives of the antibody after the last dose of a monoclonal antibody
3
[ "At", "least", "3", "half-lives", "of", "the", "antibody", "after", "the", "last", "dose", "of", "a", "monoclonal", "antibody" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 1, 1 ]
NCT02670044
12:55:chronic_disease,
History of symptomatic Clostridium difficile infection within 1 month prior to dosing
3
[ "History", "of", "symptomatic", "Clostridium", "difficile", "infection", "within", "1", "month", "prior", "to", "dosing" ]
[ 0, 0, 2, 2, 2, 2, 0, 0, 0, 0, 0, 0 ]
NCT00719888
68:98:cancer,,150:164:cancer,168:191:cancer,,345:363:cancer
patients who do not have high-risk features (for example preceding myelodysplastic syndrome [MDS], high-risk cytogenetics, >= 2 cycles to obtain CR, erythroblastic or megakaryocytic leukemia or >= CR2) must be discussed with the principal investigator (PI) prior to enrollment and at the Patient Care Conference or equivalent group such as the pediatric leukemia board as an alternative
3
[ "patients", "who", "do", "not", "have", "high-risk", "features", "(", "for", "example", "preceding", "myelodysplastic", "syndrome", "[", "MDS", "]", ",", "high-risk", "cytogenetics", ",", ">", "=", "2", "cycles", "to", "obtain", "CR", ",", "erythroblastic", "or", "megakaryocytic", "leukemia", "or", ">", "=", "CR2", ")", "must", "be", "discussed", "with", "the", "principal", "investigator", "(", "PI", ")", "prior", "to", "enrollment", "and", "at", "the", "Patient", "Care", "Conference", "or", "equivalent", "group", "such", "as", "the", "pediatric", "leukemia", "board", "as", "an", "alternative" ]
[ 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 0, 3, 3, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 3, 3, 0, 0, 0, 0 ]
NCT01959698
29:37:allergy_name,41:53:allergy_name,54:64:allergy_name,84:95:allergy_name
Known history of allergy to Captisol (a cyclodextrin derivative used to solubilize carfilzomib)
3
[ "Known", "history", "of", "allergy", "to", "Captisol", "(", "a", "cyclodextrin", "derivative", "used", "to", "solubilize", "carfilzomib", ")" ]
[ 0, 0, 0, 0, 0, 4, 0, 0, 4, 4, 0, 0, 0, 4, 0 ]